Astrana Health, Inc. (NASDAQ:ASTH) Receives $65.17 Average Target Price from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) have been given a consensus rating of "Buy" by the eight analysts that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $65.17.

A number of brokerages have issued reports on ASTH. TD Cowen started coverage on Astrana Health in a research report on Monday, October 14th. They set a "buy" rating and a $66.00 price target for the company. KeyCorp assumed coverage on shares of Astrana Health in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. Robert W. Baird boosted their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an "outperform" rating in a research report on Wednesday, November 13th. Finally, BTIG Research upped their price target on shares of Astrana Health from $60.00 to $70.00 and gave the stock a "buy" rating in a research note on Thursday, October 3rd.

Institutional Investors Weigh In On Astrana Health

A number of institutional investors and hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC bought a new stake in shares of Astrana Health during the 3rd quarter worth $34,000. Nisa Investment Advisors LLC purchased a new stake in shares of Astrana Health during the third quarter valued at $35,000. KBC Group NV purchased a new position in Astrana Health in the 3rd quarter worth about $70,000. Quarry LP purchased a new position in Astrana Health in the 3rd quarter worth about $77,000. Finally, Quest Partners LLC acquired a new stake in Astrana Health during the 3rd quarter worth about $133,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Stock Performance

Shares of Astrana Health stock traded down $1.27 during trading on Tuesday, hitting $35.52. 295,676 shares of the stock were exchanged, compared to its average volume of 213,264. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. Astrana Health has a 12 month low of $34.11 and a 12 month high of $63.20. The stock's fifty day moving average is $49.04 and its 200 day moving average is $48.12. The stock has a market cap of $2.00 billion, a PE ratio of 27.38, a P/E/G ratio of 1.80 and a beta of 1.13.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting the consensus estimate of $0.33. The firm had revenue of $478.71 million during the quarter, compared to analysts' expectations of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same quarter in the prior year, the firm earned $0.47 EPS. As a group, sell-side analysts anticipate that Astrana Health will post 1.16 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.